Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Javier Campos-Gomez
Scientist I
Close
E-mail
gomez@sri.org
jcamposg@uab.edu
jcamposg@uab.edu
Phone
205-581-2069
Visualizations
Co-author Network
Map of Science
Co-investigator Network
Javier Campos-Gomez
Scientist I
Positions
Assistant Professor - Adjunct (P)
,
Microbiology
,
Academic Joint Departments
Publications
Research
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2020
c-di-GMP modulates type IV MSHA pilus retraction and surface attachment in Vibrio cholerae
.
Nature Communications
. 11.
2020
2019
Oxylipins mediate cell-to-cell communication in Pseudomonas aeruginosa
.
Communications Biology
. 2.
2019
2018
A simple cell-based high throughput screening (HTS) assay for inhibitors of Salmonella enterica RNA polymerase containing the general stress response regulator RpoS (σ
S
)
.
Journal of Microbiological Methods
. 150:1-4.
2018
2016
Oxylipins produced by Pseudomonas aeruginosa promote biofilm formation and virulence
.
Nature Communications
. 7.
2016
2016
A novel cell-based assay to measure activity of Venezuelan equine encephalitis virus nsP2 protease
.
Virology
. 496:77-89.
2016
2016
CTXϕ: Exploring new alternatives in host factor-mediated filamentous phage replications.
.
Bacteriophage
. 6:e1128512.
2016
2016
Pf filamentous phage requires UvrD for replication in Pseudomonas aeruginosa
.
Clinical and Vaccine Immunology
. 1.
2016
2016
Tanzawaic acids, a chemically novel set of bacterial conjugation inhibitors
.
PLoS One
. 11.
2016
2015
Intracellular Degradable Hydrogel Cubes and Spheres for Anti-Cancer Drug Delivery
.
ACS Applied Materials and Interfaces
. 7:13633-13644.
2015
2015
Synthetic fatty acids prevent plasmid-mediated horizontal gene transfer
.
mBio
. 6.
2015
2014
PH-responsive hydrogel cubes for release of doxorubicin in cancer cells
.
Journal of Materials Chemistry B
. 2:2494-2507.
2014
2013
Biocompatible shaped particles from dried multilayer polymer capsules
.
Biomacromolecules
. 14:3830-3841.
2013
2011
Characterization of the single-stranded DNA binding protein pV(VGJΦ) of VGJΦ phage from Vibrio cholerae.
2011
2011
Cys mutants in functional regions of Sticholysin I clarify the participation of these residues in pore formation.
.
Toxicon
. 58:8-17.
2011
2011
Validation of a mutant of the pore-forming toxin sticholysin-I for the construction of proteinase-activated immunotoxins.
2011
2010
VEJ{phi}, a novel filamentous phage of Vibrio cholerae able to transduce the cholera toxin genes.
.
Microbiology
. 156:108-115.
2010
2009
DNA binding proteins of the filamentous phages CTXphi and VGJphi of Vibrio cholerae.
.
Journal of Bacteriology
. 191:5873-5876.
2009
2009
Anaerobic growth promotes synthesis of colonization factors encoded at the Vibrio pathogenicity island in Vibrio cholerae El Tor.
.
Research in Microbiology
. 160:48-56.
2009
2008
El Tor and Calcutta CTXPhi precursors coexisting with intact CTXPhi copies in Vibrio cholerae O139 isolates.
.
Research in Microbiology
. 159:81-87.
2008
2006
Structural and functional characterization of a recombinant sticholysin I (rSt I) from the sea anemone Stichodactyla helianthus.
.
Toxicon
. 48:1083-1094.
2006
2005
The single-stranded genome of phage CTX is the form used for integration into the genome of Vibrio cholerae.
.
Molecular Cell
. 19:559-566.
2005
2005
The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
.
Infection and Immunity
. 73:3018-3024.
2005
2003
Novel type of specialized transduction for CTX phi or its satellite phage RS1 mediated by filamentous phage VGJ phi in Vibrio cholerae.
.
Journal of Bacteriology
. 185:7231-7240.
2003
2003
Production and characterization of monoclonal antibodies to E1 Tor toxin co-regulated pilus of Vibrio cholerae.
.
Hybridoma
. 22:315-320.
2003
2003
VGJ phi, a novel filamentous phage of Vibrio cholerae, integrates into the same chromosomal site as CTX phi.
.
Journal of Bacteriology
. 185:5685-5696.
2003
2003
Construction and characterisation of O139 cholera vaccine candidates.
.
Vaccine
. 21:1282-1291.
2003
2001
Differential interleukin-8 response of intestinal epithelial cell line to reactogenic and nonreactogenic candidate vaccine strains of Vibrio cholerae.
.
Infection and Immunity
. 69:613-616.
2001
2000
Construction and characterization of a nonproliferative El Tor cholera vaccine candidate derived from strain 638.
.
Infection and Immunity
. 68:6411-6418.
2000
1999
Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate.
.
Infection and Immunity
. 67:539-545.
1999
1998
Replicating function of the RS1 element associated with Vibrio cholerae CTX phi prophage.
.
FEMS Microbiology Letters
. 164:141-147.
1998
1998
Production and characterization of a monoclonal antibody against mannose-sensitive hemagglutinin of Vibrio cholerae.
.
Hybridoma
. 17:63-67.
1998
1997
Promoter activities in Vibrio cholerae ctx phi prophage.
.
Infection and Immunity
. 65:1561-1565.
1997
1996
Tagging a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin/protease gene using a novel reporter enzyme: Clostridium thermocellum endoglucanase A.
.
Vaccine
. 14:1517-1522.
1996
1996
Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains.
.
Archives of Medical Research
. 27:275-283.
1996
Research
Principal Investigator On
Private Grant
awarded by
ARCTURUS THERAPEUTICS INC.
Severity and Progression of SARS-CoV-2 in CFTRG551D Transgenic Ferrets
awarded by
Cystic Fibrosis Foundation ^
Contact
Full Name
Javier
Campos-Gomez